BP701

盐酸奥昔布宁

British Pharmacopoeia (BP) Reference Standard

• 别名: α-苯基环己烷乙醇酸 4-(二乙基氨基)-2-丁炔酯 盐酸盐
• 经验公式（希尔记法）: C₂₂H₃₁NO₃ · HCl
• CAS号: 1508-65-2
• 分子量: 393.95
• EC號碼: 204-717-1
• MDL號碼: MFCD00072150
• 分類程式碼代碼: 41116107
• NACRES: NA.24

属性

• 等級: pharmaceutical primary standard
• API 家族: oxybutynin
• 形狀: solid
• 儲存期限: limited shelf life, expiry date on the label
• 製造商／商標名: BP
• 應用: pharmaceutical; pharmaceutical small molecule
• 格式: neat
• SMILES 字串: Cl.CCN(CC)CC#CCOC(=O)C(O)(C1CCCCC1)c2ccccc2
• InChI: 1S/C22H31NO3.ClH/c1-3-23(4-2)17-11-12-18-26-21(24)22(25,19-13-7-5-8-14-19)20-15-9-6-10-16-20;/h5,7-8,13-14,20,25H,3-4,6,9-10,15-18H2,1-2H3;1H
• InChI 密鑰: SWIJYDAEGSIQPZ-UHFFFAOYSA-N
• 基因資訊: human ... CHRM2(1129) , CHRM3(1131)

说明

一般說明

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

應用

Oxybutynin hydrochloride BP Reference standard, intended for use in laboratory tests only as specifically prescribed in the British Pharmacopoeia.

Also used in monographs such as:

Oxybutynin Tablets

Oxybutynin Oral Solution

Oxybutynin Prolonged-release Tablets

生化／生理作用

毒蕈碱型乙酰胆碱受体拮抗剂；可能通过下调生长促进基因，抑制膀胱平滑肌细胞的增殖。

包裝

Unit quantity: 100 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia

其他說明

Sales restrictions may apply.

安全信息

• 象形圖: GHS07
• 訊號詞: Warning
• 危險聲明: H302
• 防範說明: P264 - P270 - P301 + P312 - P501
• 危險分類: Acute Tox. 4 Oral
• 儲存類別代碼: 11 - Combustible Solids
• 水污染物質分類（WGK）: WGK 3
• 閃點（°F）: Not applicable
• 閃點（°C）: Not applicable